Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM Patients
Clinical trial NCT03313661 · UNKNOWN
Trial details
- NCT number
- NCT03313661
- Sponsor
- Sherief Abd-Elsalam
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-14
- Primary completion
- 2020-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.